|
|
Blood, 1 July 2004, Vol. 104, No. 1, pp. 26-33.
Prepublished online as a Blood First Edition Paper on March 16, 2004; DOI 10.1182/blood-2004-01-0182.
Previous Article | Table of Contents | Next Article 
REVIEW ARTICLES
Antigen-induced regulatory T cells
Stephane Vigouroux,
Eric Yvon,
Ettore Biagi, and
Malcolm K. Brenner
From the Center for Cell and Gene Therapy and the Departments of Pediatrics and Medicine, Baylor College of Medicine, Texas Children's Hospital, and The Methodist Hospital, Houston, TX.
Regulatory T cells participate in immunologic homeostasis by active suppression of inappropriate immune responses. Regulatory T lymphocytes expressing CD4 and CD25 antigens and naturally present in the peripheral blood were the first to be phenotypically characterized. However, their small number and antigen nonspecific suppression has prompted efforts to identify and dissect antigen-specific regulatory T cells. In this review we discuss how antigen-specific regulatory T cells can be identified, the cellular and molecular mechanisms underlying their induction and activity, and the challenges facing their potential clinical application.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Hong, H. Li, M. Chen, Y. C. Q. Zang, S. M. Skinner, J. M. Killian, and J. Z. Zhang
Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis
Int. Immunol.,
October 11, 2009;
(2009)
dxp100v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aoyama, M. Koyama, K.-i. Matsuoka, D. Hashimoto, T. Ichinohe, M. Harada, K. Akashi, M. Tanimoto, and T. Teshima
Improved outcome of allogeneic bone marrow transplantation due to breastfeeding-induced tolerance to maternal antigens
Blood,
February 19, 2009;
113(8):
1829 - 1833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Henry, C. J. Desmet, V. Garze, L. Fievez, D. Bedoret, C. Heirman, P. Faisca, F. J. Jaspar, P. Gosset, A. P. A. Jacquet, et al.
Dendritic Cells Genetically Engineered to Express IL-10 Induce Long-Lasting Antigen-Specific Tolerance in Experimental Asthma
J. Immunol.,
November 15, 2008;
181(10):
7230 - 7242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Uss, A. T. Rowshani, B. Hooibrink, N. M. Lardy, R. A. W. van Lier, and I. J. M. ten Berge
CD103 Is a Marker for Alloantigen-Induced Regulatory CD8+ T Cells.
J. Immunol.,
September 1, 2006;
177(5):
2775 - 2783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, S. Danese, and G. Leone
Tolerogenic dendritic cells: cytokine modulation comes of age
Blood,
September 1, 2006;
108(5):
1435 - 1440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Thomson, W. A. Teft, W. Chen, B. P.-L. Lee, J. Madrenas, and L. Zhang
FcR{gamma} Presence in TCR Complex of Double-Negative T Cells Is Critical for Their Regulatory Function
J. Immunol.,
August 15, 2006;
177(4):
2250 - 2257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Cao, E. Armstrong, A. Schlachterman, L. Wang, D. K. Okita, B. Conti-Fine, K. A. High, and R. W. Herzog
Immune deviation by mucosal antigen administration suppresses gene-transfer-induced inhibitor formation to factor IX
Blood,
July 15, 2006;
108(2):
480 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Biagi, R. Rousseau, E. Yvon, M. Schwartz, G. Dotti, A. Foster, D. Havlik-Cooper, B. Grilley, A. Gee, K. Baker, et al.
Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia
Clin. Cancer Res.,
October 1, 2005;
11(19):
6916 - 6923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dercamp, K. Chemin, C. Caux, G. Trinchieri, and A. P. Vicari
Distinct and Overlapping Roles of Interleukin-10 and CD25+ Regulatory T Cells in the Inhibition of Antitumor CD8 T-Cell Responses
Cancer Res.,
September 15, 2005;
65(18):
8479 - 8486.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|